Merck
CN
Search Within
文件类型

100-83-4

应用筛选条件
关键词:'100-83-4'
显示 1-30 共 744 条结果 关于 "100-83-4" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
92 100 91 70 99 98 97 3 4 7 PDK1 104 115 92 36 70 99 85 86 89 87 88 76 81 110 105 98 84 85 69 PKBα 17 90 88 27 67 79 89
The Effective Use of Protein Kinase Inhibitors
84 6 6 4 86 113 99 83 60 52 78 107 107 100 107 106 103 41 19 84 22 94 57 15 53 45 65 75 93 43 59 97 53 74 23 96 102 60
Data Sheet - P4113
degraded by the 26S proteasome in an ATP-dependent process, and free ubiquitin is released.4-7 Reagent S-100 Proteasome Fraction is supplied as a solution in 50 mM HEPES, pH 7.6, 20 mM NaCl, 0.5 mM
Data Sheet - SCC315
Leu15]-Gastrin I, reconstituted to 100 μM in PBS/ 0.1% BSA Sigma G9145 10 µL 20 nM Prostaglandin E2, reconstituted to 100 μM in DMSO Sigma P6532 10 µL 20 nM A-83-01, reconstituted to 1 mM in
Data Sheet - SCC316
Leu15]-Gastrin I, reconstituted to 100 μM in PBS/ 0.1% BSA Sigma G9145 10 µL 20 nM Prostaglandin E2, reconstituted to 100 μM in DMSO Sigma P6532 10 µL 20 nM A-83-01, reconstituted to 1 mM in
Data Sheet - F3901
1982). 2. Mosmann, T., et al., Proc. Nat. Acad. Sci. USA, 83, 5654 (1986). 3. Paul, W., and Ohara, J., Ann. Rev. Immunol., 5, 429 (1987). 4. Park, L., et al., J. Exp. Med., 166, 476 (1987). 5. Jung
Data Sheet - P7097
1982). 2. Mosmann, T., et al., Proc. Nat. Acad. Sci. USA, 83, 5654 (1986). 3. Paul, W., and Ohara, J., Ann. Rev. Immunol., 5, 429 (1987). 4. Park, L., et al., J. Exp. Med., 166, 476 (1987). 5. Jung
Data Sheet - F6276
7251 (1987). 3. Van Snick, J., Ann. Rev. Immunol., 8., 253 (1990). 4. Van Snick, J., et al., Proc. Natl. Acad. Sci. USA, 83, 9679 (1986). 5. Jung, T., et al., J. Immunol. Methods, 159, 197
Product Information Sheet - T3766
Potential anticancer agents. LXI. A novel synthesis of "spongo" nucleosides. J. Am. Chem. Soc., 83, 2208 (1961). 2. Rubsam, L. Z., et al., Superior cytotoxicity with ganciclovir compared with
Data Sheet - I7776
recombinant mouse IL-4 at 2 ng/lane under non-reducing and reducing conditions. Endotoxin: 83, 2061 (1986).
Data Sheet - I7034
F., et al., Proc. Natl. Acad. Sci., USA, 83, 2061 (1986). 2. Noma, Y., Nature, 319, 640 (1986). 3. Howard, M., et al., J. Exp. Med., 155, 914 (1982). 4. Roehm, N.W., et al., J. Exp. Med., 160
Data Sheet - C9354
Langenbach, R., et al., Cell, 83, 483 (1995). 9. O’Neill, P. O., and Ford-Hutchinson, A. W., FEBS Letts., 330, 156 (1993). 10. Tsujii, M., and DuBois, R. N., Cell, 83, 493 (1995). KAA 06/01
Data Sheet - I8784
Lee, F., et al., Proc. Natl. Acad. Sci., USA, 83, 2061(1986). 2. Noma, Y., Nature, 319, 640 (1986). 3. Howard, M., et al., J. Exp. Med., 155, 914 (1982). 4. Roehm, N.W., et al., J. Exp. Med., 160, 679
Product Information Sheet - G1126
Product Description Molecular Formula: C5H9NO4 • H2O Molecular Weight: 165.1 CAS Number: 19285-83-7 Melting Point: 225-227 °C (with decomposition) Synonyms: DL-glutaminic acid, DL-α-aminoglutaric
Color Card 1.10049 - MQuant Molybdenum Test (Don't use printout for evaluation)
0 5 20 50 100 250 Mo 0 8 33 83 166 415 MoO42- mg/l 5 ml pH 4 - 6 15 - 2 5 °C 1
Product Information Sheet-11175033910
Concentration 1 – Dilution of probe and Vial 4 – – 1 ng/μl 2 2 1 198 1:100 10 pg/μl 3 15 2 35 1:3.3 3 pg/μl 4 5 2 45 1:10 1 pg/μl 5 5 3 45 1:10 0.3
Anti-Tau-1, clone PC1C6 - Data Sheet
Motility and the Cytoskeleton 8:210. 7. Wood, J.G. et al. (1986) PNAS.USA 83:4040. 8. Grundke, Iqbal et al. (1986) PNAS.USA 83:4913. 9. Shelanski, M.L. et al. (1973) PNAS.USA 70:765. 10. Hsu, S. et
Product Information Sheet - T4DNAPOL-RO
21 .1 10 06 83 50 01 19 4. Supplementary Information y Version: 19 T4 DNA Polymerase from T4 plasmid pTL43W infected Escherichia coli 71-18 6 sigma-aldrich.com 4. Supplementary Information
Application Note - LightCycler 480 Real-Time PCR System for Relative Quantification
ce (4 83 –5 33 ) 22.749 17.749 12.749 7.749 2.749 0 4 8 12 16 20 24 28 32 36 40 44 Cycles Reference amplification curves b c
MultiScreen Solubility Filter plate: Integration with Detection Techniques
Table 4. Entry Compound Screening ratio Solubility classification Shake Flask (�M) 20 β-estradiol 0.09 marginal 21 21 clotrimazole 0.06 marginal 1 22 digoxin 0.05 marginal 83 23 ibuprofen
Data Sheet - K4261
Cell, 83, 879-888 (1995). 4. Therrien, M., et al., Genes Dev., 10, 2684-2695 (1996). 5. Michaud, N.R., et al., Proc. Natl. Acad. Sci. USA, 94, 12792-12796 (1997). 6. Downward, J., Cell, 83, 831-834
Product Information Sheet -SRP3096
253 (1990). 4. Kishimoto, T., Clin. Rev. Allergy Immunol., 28, 197 (2005). 5. Nordan, R., et al., J. Immunol., 139, 813 (1987). 6. Van Snick, J., et al., Proc. Nat. Acad. Sci. USA, 83, 9679 (1986
Product Information Sheet - RAB0058
92 93 Expected Range (%)
Data Sheet - S1076 - Lot SLBB2373
0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼83 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 83–113 nmole/min/mg (see Figure 2) Precautions and Disclaimer This
Product Information Sheet - SE120057
function relationship of follicle-stimulating hormone and its receptor. Hum. Reprod. Update, 4(3), 260- 83 (1998). 3. Desai, M.P. et al., Importance of selection of separation system in the development
Data Sheet - S1076 - Lot 031M0743
0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼83 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 83–113 nmole/min/mg (see Figure 2) Precautions and Disclaimer This
Data Sheet - S1076
mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼83 kDa Precautions and Disclaimer This product is for R&D use only, not for drug, household, or other
Data Sheet - S1076 - Lot 100M0859
0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼83 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 83–113 nmole/min/mg (see Figure 2) Precautions and Disclaimer This
Data Sheet - S1076 - Lot 109K0795
0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼83 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 83–113 nmole/min/mg (see Figure 2) Precautions and Disclaimer This
Data Sheet - S1076 - Lot 040M0737
0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼83 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 83–113 nmole/min/mg (see Figure 2) Precautions and Disclaimer This
1/25